Maarten A. De Jong - Publications

Surgical outcomes in surgical oncology patients who participated in a family involvement program.

Journal: Surgery

Published: November 27, 2023

Environmental Selection Shapes Bacterial Community Composition in Traditionally Fermented Maize-Based Foods from Benin, Tanzania and Zambia.

Journal: Microorganisms

Published: May 16, 2022

Digital arterial pressure pulse wave analysis and cardiovascular events in the general population: the Prevention of Renal and Vascular End-stage Disease study.

Journal: Journal of hypertension

Published: May 07, 2020

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation.

Journal: Journal of clinical medicine

Published: April 30, 2020

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 08, 2019

No increased risk of transfusion-transmissible infections after tattooing, body piercing, or acupuncture among blood donors in the Netherlands.

Journal: Transfusion

Published: March 08, 2019

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.

Journal: PLoS medicine

Published: January 04, 2019

Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: April 11, 2018

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 01, 2018

Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT).

Journal: Nephron

Published: May 17, 2016

Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.

Journal: Journal of the American Society of Nephrology : JASN

Published: April 07, 2016

Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 15, 2015